PTK2B and neoplasm: The fusion protein Rab22a-NeoF1 either directly binds and activates RhoA, or is secreted together with its binding partner PKY2 by tumor-positive cells, taken up by tumor-negative cells, and facilitating RhoA activation via PYK2 (3, 49).